Abstract: Methods, systems, and storage media for generating audio data includes receiving a text input. The method also includes receiving a plurality of representative audio sources and encoding the plurality of representative audio sources into a plurality of audio tokens. The method includes encoding the text input into a plurality of text representations. The method comprises mapping each audio tokens of the plurality of audio tokens to a text representation of the plurality of text representations. The method also comprises determining a relationship score based on mapping each audio tokens to the text representation, wherein the relationship score identifies a distribution of audio tokens from the plurality of audio tokens. The method and systems can also comprise decoding the subgroup of audio tokens to yield a reconstructed audio source.

Abstract: Molecular complexes and compositions containing the same are disclosed herein. More specifically, carbohydrate polymers, for example hyaluronic acid or a salt thereof, are complexed with a biologically active compound selected from natural products and nutrients (amino acids, amino esters, hydroxy acids, hydroxy esters, vitamins, cannabinoids, etc.), and active pharmaceutical ingredients to create stabilized molecular complexes. The complexation can be conveniently achieved by means of a resonant acoustic mixing process.

Abstract: Crosslinked hyaluronic acid compositions are disclosed herein. More specifically, the hyaluronic acid is crosslinked with a biologically active compound selected from amino acids, amino esters, hydroxy acids, hydroxy esters, vitamins, stabilizers and mixtures thereof. The crosslinking is conveniently achieved by means of an extrusion process.

Abstract: A water-soluble gel polymer matrix comprising hyaluronic acid and an antitumor agent is described herein. The antitumor agent is crosslinked with the hyaluronic acid by at least one of covalent and/or non-covalent bonding resulting in improved water solubility of the antitumor agent. Pharmacokinetic studies illustrated that the antitumor agent exhibits enhanced Cmax (maximum drug plasma concentration) and Tmax (time required to reach Cmax) values.

Abstract: Crosslinked hyaluronic acid compositions are disclosed herein. More specifically, the hyaluronic acid is crosslinked with a biologically active compound selected from amino acids, amino esters, hydroxy acids, hydroxy esters, vitamins, stabilizers and mixtures thereof. The crosslinking is conveniently achieved by means of an extrusion process.

Abstract: The invention relates to compositions which are useful for inhibiting prostaglandin F2? receptor. The compositions include, but are not limited to, linear peptides, peptide analogs, and peptidomimetics. Methods of using the compositions of the invention to treat preterm labor and dysmenorrhea are disclosed.

Abstract: The invention relates to compositions which are useful for inhibiting prostaglandin F2? receptor. The compositions include, but are not limited to, linear peptides, peptide analogs, and peptidomimetics. Methods of using the compositions of the invention to treat preterm labor and dysmenorrhea are disclosed.

Abstract: The invention relates to compositions which are useful for inhibiting prostaglandin F2?receptor. The compositions include, but are not limited to, linear peptides, peptide analogs, and peptidomimetics. Methods of using the compositions of the invention to treat preterm labor and dysmenorrhea are disclosed.

Abstract: The invention relates to compositions which are useful for inhibiting prostaglandin F2? receptor. The compositions include, but are not limited to, linear peptides, peptide analogs, and peptidomimetics. Methods of using the compositions of the invention to treat preterm labor and dysmenorrhea are disclosed.